2026年11月4日，欧洲议会癌症和罕见疾病小组和乔治斯·乔治奥 MEP 将召集专家对话，讨论如何更好地满足癌症和罕见疾病患者跨境医疗服务的需求。欧洲罕见疾病组织（EURORDIS）、欧洲癌症组织（ECO）和欧洲儿科[…]
正文为英文原文（标题与摘要已译成中文），如需中文全文可用浏览器翻译或点击「阅读原文」。
October 2026On 4 November, the European Parliament Intergroup on Cancer and Rare Diseases and Giorgos Georgiou MEP, will convene an expert dialogue on how Europe’s cross-border healthcare framework can better meet the needs of people living with cancer and rare diseases.
EURORDIS – Rare Diseases Europe, the European Cancer Organisation (ECO) and the European Society for Paediatric Oncology (SIOPE), form the Intergroup’s secretariat.
The expert dialogue will examine the barriers patients continue to face when seeking healthcare across borders, including administrative complexity, financial burdens, limited awareness of patients’ rights, and delays in accessing specialised care.
It will also explore how modernised EU rules and stronger implementation can improve access to timely diagnosis, multidisciplinary expertise, innovative treatments, clinical trials and research.
The expert dialogue will consider how effective cross-border pathways can strengthen access to European Reference Networks, specialised clinical trials and other forms of highly specialised care, while ensuring that patients can access the expertise they need regardless of where they live.
Giorgos Georgiou MEP, Vlad Voiculescu MEP, Tilly Metz MEP, Tomislav Sokol MEP and Marta Temido MEP will take part in the discussion, alongside healthcare professionals, researchers and patient representatives, to examine how Europe can build a more patient-centred and effective framework for cross-border healthcare.
🗓️ Date: 4 November 2026, 9:30 AM – 11:00 AM📍 Where: Brussels, BelgiumIn-person registration has now closed for the event, but more information about livestreaming shall be made available shortly.
以上正文由系统自动提取自原文页面，仅供阅读便利；如显示不全，请点击下方「阅读原文」。